Clarisa R Gracia1, Ellen W Freeman, Mary D Sammel, Hui Lin, Marjori Mogul. 1. Department of Obstetrics/Gynecology, Center for Clinical Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA. cgracia@obgyn.upenn.edu
Abstract
OBJECTIVE: To examine the relationship between reproductive hormonal dynamics and sexual dysfunction assessed in a cohort of women approaching menopause. METHODS: Women in the Penn Ovarian Aging Study were assessed at yearly intervals for 3 years with early follicular hormone measurements (estradiol, follicle-stimulating hormone, luteinizing hormone [LH], sex hormone binding globulin, dehyroepiandrosterone sulfate [DHEAS], total testosterone), anthropometric measures, and extensive questionnaires including the Female Sexual Function Index. Univariable analyses were performed to determine the association between hormones, menopausal status, and sexual dysfunction. Multivariable linear and logistic regression models were created to examine the influence of hormones on sexual function adjusting for the effect of potential confounders. RESULTS: The final multivariable model indicated that sexual dysfunction increased with advanced menopausal status, with postmenopausal women being 2.3 times as likely to experience sexual dysfunction compared with premenopausal women (odds ratio 2.3, 95% confidence interval [CI] 1.3-4.1). Low DHEAS serum concentrations were associated with decreased sexual function (odds ratio 1.59, 95% CI 1.19-2.14). Additional risk factors associated with sexual dysfunction included absence of a sexual partner (11.2, 95% CI 6.9-18.1), high anxiety (3.8, 95% CI 1.6-9.2), and children under the age of 18 living at home (1.6, 95% CI 1.1-5.5). Lubrication, orgasm, and pain were specific aspects of sexuality negatively affected by menopause. CONCLUSION: This study confirms the observation that sexual dysfunction increases over the menopausal transition. Several factors associated with sexual dysfunction include low DHEAS, absence of a sexual partner, anxiety, and children under the age of 18 living at home. LEVEL OF EVIDENCE: II.
OBJECTIVE: To examine the relationship between reproductive hormonal dynamics and sexual dysfunction assessed in a cohort of women approaching menopause. METHODS:Women in the Penn Ovarian Aging Study were assessed at yearly intervals for 3 years with early follicular hormone measurements (estradiol, follicle-stimulating hormone, luteinizing hormone [LH], sex hormone binding globulin, dehyroepiandrosterone sulfate [DHEAS], total testosterone), anthropometric measures, and extensive questionnaires including the Female Sexual Function Index. Univariable analyses were performed to determine the association between hormones, menopausal status, and sexual dysfunction. Multivariable linear and logistic regression models were created to examine the influence of hormones on sexual function adjusting for the effect of potential confounders. RESULTS: The final multivariable model indicated that sexual dysfunction increased with advanced menopausal status, with postmenopausal women being 2.3 times as likely to experience sexual dysfunction compared with premenopausal women (odds ratio 2.3, 95% confidence interval [CI] 1.3-4.1). Low DHEAS serum concentrations were associated with decreased sexual function (odds ratio 1.59, 95% CI 1.19-2.14). Additional risk factors associated with sexual dysfunction included absence of a sexual partner (11.2, 95% CI 6.9-18.1), high anxiety (3.8, 95% CI 1.6-9.2), and children under the age of 18 living at home (1.6, 95% CI 1.1-5.5). Lubrication, orgasm, and pain were specific aspects of sexuality negatively affected by menopause. CONCLUSION: This study confirms the observation that sexual dysfunction increases over the menopausal transition. Several factors associated with sexual dysfunction include low DHEAS, absence of a sexual partner, anxiety, and children under the age of 18 living at home. LEVEL OF EVIDENCE: II.
Authors: Christiana von Hippel; Avanti Adhia; Shoshana Rosenberg; S Bryn Austin; Ann Partridge; Rulla Tamimi Journal: Womens Health Issues Date: 2019-05-23
Authors: Hugh S Taylor; Aya Tal; Lubna Pal; Fangyong Li; Dennis M Black; Eliot A Brinton; Matthew J Budoff; Marcelle I Cedars; Wei Du; Howard N Hodis; Rogerio A Lobo; JoAnn E Manson; George R Merriam; Virginia M Miller; Frederick Naftolin; Genevieve Neal-Perry; Nanette F Santoro; Sherman M Harman Journal: JAMA Intern Med Date: 2017-10-01 Impact factor: 21.873
Authors: Beth A Prairie; Stephen R Wisniewski; James Luther; Rachel Hess; Rebecca C Thurston; Katherine L Wisner; Joyce T Bromberger Journal: J Womens Health (Larchmt) Date: 2015-01-26 Impact factor: 2.681
Authors: Nancy E Avis; Sarah Brockwell; John F Randolph; Shunhua Shen; Virginia S Cain; Marcia Ory; Gail A Greendale Journal: Menopause Date: 2009 May-Jun Impact factor: 2.953
Authors: Ana L R Valadares; Aarão M Pinto-Neto; Maria J Osis; Maria H Sousa; Lúcia Costa-Paiva; Délio M Conde Journal: Clinics (Sao Paulo) Date: 2008-12 Impact factor: 2.365